Related Experiment Videos
Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease
1Department of Nuclear Medicine, Straub Clinic & Hospital, Honolulu, Hawaii 96813.
Summary
The optimal radioactive iodine (131I) dose for Graves' disease cure prioritizes hyperthyroidism resolution over avoiding hypothyroidism. Higher doses, particularly above 5 mCi, directly correlate with cure rates, with adjustments for gland size.
Area of Science:
- Endocrinology
- Nuclear Medicine
- Thyroidology
Background:
- Graves' disease is a common cause of hyperthyroidism.
- Radioiodine (131I) therapy is a standard treatment for Graves' disease.
- Hypothyroidism is a frequent consequence of 131I treatment.
Purpose of the Study:
- To determine the optimal 131I dose for curing hyperthyroidism.
- To analyze factors influencing cure rates after 131I therapy.
- To balance cure efficacy with the incidence of hypothyroidism.
Main Methods:
- A retrospective analysis of 605 patients treated with escalating 131I doses (3-10 mCi).
- Statistical analysis (chi-square) to evaluate relationships between dose, age, sex, gland weight, 24-hr thyroidal uptake, and cure.
- Extrapolation of cure estimates for doses exceeding 10 mCi based on literature.
Main Results:
- A direct relationship between 131I dose and cure was observed between 5 and 10 mCi.
- No significant correlation found between cure and patient age, sex, or 24-hr uptake (>30%).
- An inverse relationship between cure and thyroid gland weight was identified.
Conclusions:
- The optimal 131I dose for hyperthyroidism cure can be approximated by starting with 10 mCi.
- Dose adjustments are recommended for patients with large thyroid glands or specific circumstances.
- Prioritizing hyperthyroid cure is essential, accepting hypothyroidism as a manageable outcome.